As we head into a weekend that’s predicted to be a scorcher for many parts of the country, we take a look at the week that was in Australian pharmacy
Roy Morgan Research confirmed a drop in colds and flu, but a rise in mental health concerns, during 2020 as a result of the COVID-19 pandemic and measures to combat it. NSW Minister for Mental Health, Regional Youth and Women Bronnie Taylor lauded the way community pharmacy has handled the mental health fallout from the pandemic, including how the Pharmacy Guild managed training.
The TGA confirmed schedule changes for several medicines including ibuprofen, despite pharmacy opposition to some proposals. Pharmacy experts praised the Society of Hospital Pharmacists of Australia‘s new framework to support the identification and referral by hospital-based clinicians of high risk patients to review pathways. Talking of SHPA, we looked at how its annual report highlighted the way pharmacists have stepped up to meet 2020’s challenges; and congratulations to all the pharmacists who were nominated for and won its 2020 awards.
The Australian Institute of Health and Welfare examined how sales of asthma medication spiked in areas affected by the 2019–20 bushfires. Chemist Warehouse was listed as one of Australians’ favourite brands in a YouGov survey.
PDL offered some timely advice on electronic prescriptions. PPA‘s Geoff March looked at where pharmacists sit compared to other professions when it comes to issues like wage theft and notification about performance.
We looked at a spectacular US case where a pharmacist and his Darknet conspirator were sentenced for their plot to firebomb a rival pharmacy.
And as November draws to a close, don’t forget to check out the luxuriant facial hair sported by our editor, Chris Brooker, in his efforts—with Pharmacy Daily Editor, Nick O’Donoghue—to raise funds for the Pharmacists Support Service.